Jay Skyler

Jay S.
Skyler currently serves as Deputy Director & Professor at the Diabetes Research Institute since 2012, Director at Moerae Matrix, Inc., Independent Director at SAB Biotherapeutics, Inc. since 2024, and Professor at the University of Miami since 2004.
Former roles include Independent Director at Amylin Pharmaceuticals, Inc. from 2011 to 2012, Independent Director at DexCom, Inc. from 2002 to 2023, Director at Aerami Therapeutics, Inc. from 2013 to 2014, Director at MiniMed, Inc., Director at Intarcia Therapeutics, Inc., Independent Director at Applied Therapeutics, Inc., Chairman-Study at the National Institute of Diabetes & Digestive & Kidney Diseases, Chairman-Subspecialty Societies Council at the American College of Physicians, Vice President at the International Diabetes Federation, Editor-in-Chief at the American Diabetes Association, Member-Examining Board at the American Board of Internal Medicine, and President of the Southern Society for Clinical Investigation.
Education includes undergraduate studies at The Pennsylvania State University and a doctorate from Sidney Kimmel Medical College.